Ron Handels

57 papers receiving 1.0k citations

Hit Papers

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint 2023 · 75 citations
750+1+2Years since publication255075

Peers

Ron Handels
Comparison fields: 5 of 108
  • Psychiatry and Mental health 630
  • Geriatrics and Gerontology 104
  • Physiology 329
  • Economics and Econometrics 279
  • Neurology 77
Replace Kristin Kahle‐Wrobleski with:
Kristin Kahle‐Wrobleski United States
J. Scott Andrews United States
Guk‐Hee Suh South Korea
Eugene Tang United Kingdom
Katrin Seeher Australia
Suzanne A. Ligthart Netherlands
Nathaniel A. Chin United States
Marcel Olde‐Rikkert Netherlands
Ingrid S. van Maurik Netherlands
Heather Davila United States
Ron Handels relative to Kristin Kahle‐Wrobleski United States Kristin Kahle‐Wrobleski's profile →
Citations per field
00.5×1.5×2.2×
Kristin Kahle‐Wrobleski · 1×
Citations per year

Countries citing papers authored by Ron Handels

Since Specialization
Citations

This map shows the geographic impact of Ron Handels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Handels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Handels more than expected).

Fields of papers citing papers by Ron Handels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Handels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Handels. The network helps show where Ron Handels may publish in the future.

Co-authors

The 25 scholars most cited alongside Ron Handels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ron Handels Line = papers co-authored together Ron Handels links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012151
2 201086
3
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Hit paper breakdown →
202375
4 201757
5 201452
6 201948
7 201639
8 201238
9 201335
10 201730
11 201728
12 202026
13 202225
14 201223
15 201920
16 202018
17 201317
18 201816
19 202216
20 201616

About Ron Handels

Ron Handels is a scholar working on Psychiatry and Mental health, Economics and Econometrics, General Health Professions, Geriatrics and Gerontology and Sociology and Political Science, having authored 61 papers that have together received 1.0k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (38 papers), Health Systems, Economic Evaluations, Quality of Life (36 papers), Geriatric Care and Nursing Homes (12 papers), Frailty in Older Adults (10 papers), Alzheimer's disease research and treatments (6 papers), Chronic Disease Management Strategies (6 papers), Pharmaceutical Economics and Policy (6 papers) and Intergenerational Family Dynamics and Caregiving (5 papers). The work is most often cited by research in Psychiatry and Mental health (630 citations), Geriatrics and Gerontology (104 citations), Physiology (329 citations), Economics and Econometrics (279 citations) and Neurology (77 citations). Ron Handels has collaborated with scholars based in Netherlands, Sweden and United Kingdom. Frequent co-authors include Anders Wimo, Frans R.J. Verhey, Claire Wolfs, Pieter Jelle Visser, Pauline Aalten, Linus Jönsson, Bengt Winblad, Stephanie J. B. Vos, Ineke A. van Rossum and Johan L. Severens. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, BMJ Open, Aging & Mental Health and Journal of the American Medical Directors Association.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact